Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1984 Oct;83(2):427–432. doi: 10.1111/j.1476-5381.1984.tb16503.x

Cardiovascular studies with SK&F 93319, an antagonist of histamine at both H1- and H2-receptors.

C A Harvey, D A Owen
PMCID: PMC1987123  PMID: 6148984

Abstract

Cardiovascular studies have been made in anaesthetized cats with SK&F 93319, an antagonist of histamine at both H1- and H2-receptors. SK&F 93319, 8 X 10(-8) and 4 X 10(-7) mol kg-1 min-1 antagonized depressor responses to injections of histamine and the maximum displacement of histamine dose-response curves exceeded that which can be obtained with either an H1-receptor antagonist or an H2-receptor antagonist alone. SK&F 93319, 8 X 10(-8) and 4 X 10(-7) mol kg-1 min-1, also caused dose-dependent antagonism of histamine-induced falls in blood pressure and total peripheral resistance during intravenous infusions of histamine. SK&F 93319 inhibited depressor responses to intravenous injections of 2-(2-aminoethyl)pyridine, dimaprit and impromidine. The displacement of the 2-(2-aminoethyl)pyridine dose-response curve was similar to the displacement of histamine dose-response curves. SK&F 93319 caused greater displacement of dimaprit or impromidine dose-response curves than of histamine or 2-(2-aminoethyl)pyridine dose-response curves. SK&F 93319 was an effective antagonist of histamine, 2-(2-aminoethyl)pyridine or dimaprit-induced vasodilatation in femoral and gastric vasculature. SK&F 93319 has been shown to be an effective antagonist of vascular responses to histamine in anaesthetized cats. SK&F 93319 appeared to be more effective as an H2-receptor antagonist than as an H1-receptor antagonist in these vascular studies.

Full text

PDF
427

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black J. W., Duncan W. A., Durant C. J., Ganellin C. R., Parsons E. M. Definition and antagonism of histamine H 2 -receptors. Nature. 1972 Apr 21;236(5347):385–390. doi: 10.1038/236385a0. [DOI] [PubMed] [Google Scholar]
  2. Black J. W., Owen D. A., Parsons M. E. An analysis of the depressor responses to histamine in the cat and dog: involvement of both H1- and H2-receptors. Br J Pharmacol. 1975 Jul;54(3):319–324. doi: 10.1111/j.1476-5381.1975.tb07571.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chipman P., Glover W. E. Histamine H2-receptors in the human peripheral circulation. Br J Pharmacol. 1976 Apr;56(4):494–496. doi: 10.1111/j.1476-5381.1976.tb07463.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Durant G. J., Duncan W. A., Ganellin C. R., Parsons M. E., Blakemore R. C., Rasmussen A. C. Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptors. Nature. 1978 Nov 23;276(5686):403–405. doi: 10.1038/276403a0. [DOI] [PubMed] [Google Scholar]
  5. Durant G. J., Ganellin C. R., Parsons M. E. Chemical differentiation of histamine H1- and H2-receptor agonists. J Med Chem. 1975 Sep;18(9):905–909. doi: 10.1021/jm00243a009. [DOI] [PubMed] [Google Scholar]
  6. Flynn S. B., Johnston B. M., Owen D. A. The cardiovascular response to dimaprit, a selective histamine H2-receptor agonist. Br J Pharmacol. 1977 Sep;61(1):101–107. [PMC free article] [PubMed] [Google Scholar]
  7. Flynn S. B., Owen D. A. Histamine receptors in peripheral vascular beds in the cat. Br J Pharmacol. 1975 Oct;55(2):181–188. doi: 10.1111/j.1476-5381.1975.tb07627.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harvey C. A., Owen D. A., Shaw K. D. Evidence for both histamine H1- and H2-receptors in the gastric vasculature of the cat. Br J Pharmacol. 1980 May;69(1):21–27. doi: 10.1111/j.1476-5381.1980.tb10878.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Harvey C. A., Owen D. A. Time dependence of the interaction between histamine and histamine receptor antagonists in the cardiovascular system [proceedings]. Br J Pharmacol. 1980 Jan;68(1):187P–187P. [PMC free article] [PubMed] [Google Scholar]
  10. Owen D. A., Harvey C. A., Boyce M. J. Effects of histamine on the circulatory system. Klin Wochenschr. 1982 Sep 1;60(17):972–977. doi: 10.1007/BF01716957. [DOI] [PubMed] [Google Scholar]
  11. Owen D. A., Harvey C. A., Gristwood R. W. Cardiovascular studies with impromidine (SK&F 92676), a new very potent and specific histamine H2-receptor agonist. J Pharm Pharmacol. 1979 Sep;31(9):577–582. doi: 10.1111/j.2042-7158.1979.tb13595.x. [DOI] [PubMed] [Google Scholar]
  12. Owen D. A. The effects of histamine and some histamine-like agonists on blood pressure in the cat. Br J Pharmacol. 1975 Oct;55(2):173–179. doi: 10.1111/j.1476-5381.1975.tb07626.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES